Lyell Immunopharma Inc (LYEL) Stock Price, Quote, News & History

LYELNASDAQ
$15.53
0.181.17%
At close: Aug 21, 5:00 PM EST
$15.53
N/A
After Hours: Aug 21, 4:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-133.26M
Investing Cash Flow (TTM)
4.98M
Financing Cash Flow (TTM)
102.47M
Free Cash Flow (TTM)
-133.97M
Capital Expenditure (TTM)
-711.00K
Net Change in Cash (TTM)
-25.82M

Analyst Trends and Forecast

1
May
4
Jun
1
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$211.80M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
11906.31
PB Ratio (TTM)
1.60
Earnings Yield % (TTM)
-82.97%
Earnings Yield % (FWD)
-46.68%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$9.54

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$72.99M
Debt to Equity
0.16
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$15.54
Close
$15.53
Volume / Avg.
104.91K / 186.23K
Day Range
$15.20 - $16.16
52 Wk Range
10.49 - 45.00
Market Cap
$380.56M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
59
Short Interest
5.87%
Days to Cover
8.66

About

Sector
Health Care
Industry
Biotechnology
Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Lyell Immunopharma (LYEL) stock?

A

You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lyell Immunopharma (LYEL) competitors?

Q

What is the forecast, or price target, for Lyell Immunopharma (LYEL) stock?

A

Lyell Immunopharma has a consensus price target of $26.56.

Q

What is the current price for Lyell Immunopharma (LYEL)?

A

The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $15.53 last updated August 21, 2026 at 4:00 PM EDT.

Q

Does Lyell Immunopharma (LYEL) pay a dividend?

A

There are no upcoming dividends for Lyell Immunopharma.

Q

When is Lyell Immunopharma (NASDAQ:LYEL) reporting earnings?

A

Lyell Immunopharma does not have any upcoming earnings scheduled.

Q

Is Lyell Immunopharma (LYEL) going to split?

A

There is no upcoming split for Lyell Immunopharma.

Q

What sector and industry does Lyell Immunopharma (LYEL) operate in?

A

Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.